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Objectives. Tuberculous lymphadenitis is themost common form of extrapulmonary tuberculosis (TB) with a female and paediatric
preponderance, postulated to be due to differences in the immune response. The aim of this study was to analyze the differences in
the serum cytokine levels of tuberculous lymphadenitis patients with respect to age and gender.Methods. A multiplex bead-based
enzyme-linked immunosorbent assay was used to measure IFN-𝛾, TNF-𝛼, GM-CSF, IL-1𝛽, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12,
IL-15, and IL-17 levels in sera of patients (𝑛 = 86) and healthy controls (𝑛 = 23). Results. Levels of IFN-𝛾, TNF-𝛼, GM-CSF, IL-1𝛽,
IL-2, IL-4, and IL-6 were higher in adult patients than in controls, while those of IL-12 were lower (𝑃 < 0.05). Children had lower
levels of TNF-𝛼, GM-CSF, and IL-5 and higher levels of IL-2 compared with adult patients (𝑃 < 0.05). The male adult patients had
higher levels of IL-17 and lower levels of IL-12 compared with female adult patients (𝑃 < 0.05). Conclusion. There were significant
differences in the levels of circulating cytokines with respect to gender and age. Children had generally lower levels of cytokines
as compared to adults, which could make them more susceptible. Findings do not support that female preponderance is due to
differences in immune response.
1. Introduction
Extrapulmonary tuberculosis (TB) constitutes about 15 to
20% of all cases of TB. The true rate may be even higher
due to incomplete reporting in many developing countries.
The annual global incidence of EPTB has been increasing
in last decades due to the changing TB control practices,
spread of Human Immune Deficiency Virus (HIV), and
the population growth. Lymphadenitis is the most common
form of extrapulmonary TB with a female and paediatric
preponderance [1–4]. Children belong to the category of rela-
tively susceptible individuals to develop TB.Themechanisms
by which women and children become more susceptible
to develop TB lymphadenitis are not fully understood. TB
lymphadenitis is usually a self-contained disease and there
is a granulomatous immune response in the lymph nodes
which is considered to be a correlate of protective immunity.
Formation of granulomas is achieved by cell-mediated immu-
nity orchestrated by a complex interplay of cytokines and
chemokines [5]. However, despite an effective cell-mediated
immunity, eradication of the pathogen is not achieved and
the disease runs a chronic course [6]. Mechanisms involved
in the regulation of immune responses in TB lymphadenitis
are not clear, and the knowledge of systemic levels of different
cytokines is limited. Few studies have sought to determine the
cytokine balance at the systemic level in a small number of
patients with TB lymphadenitis by using the ex vivo cytokine
production capacity of isolated peripheral blood mononu-
clear cells or CD4+ T cells after stimulation [7, 8]. The ex
vivo stimulated production of cytokines does not necessarily
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Table 1: The characteristics of the study population.
Adults (𝑛 = 61) Children(𝑛 = 25)
Age in years Median 28,range 16–75
Median 9, range
2–14
Males (𝑛) 27 10
Females (𝑛) 34 15
Culture positive (𝑛) 13/61∗ 3/23∗
HIV positive (𝑛) 5/44∗ 0/12∗
BCG vaccinated (𝑛) 45/57∗ 21/25∗
𝑛 = number of cases; ∗denominator denotes the number of cases where
results were available.
provide insight into the actual status of the cytokine network
in vivo. Indeed, in patients with severe bacterial infections
much of the observed organ injury is considered to be
related to enhanced in vivo production of proinflammatory
cytokines, while peripheral blood mononuclear cells isolated
from those patients produce significantly less cytokines upon
stimulation as compared to cells from healthy controls [9].
We therefore decided to investigate unstimulated serum sam-
ples fromTB lymphadenitis patients.The aimwas to compare
the immune response among TB lymphadenitis patients with
respect to gender and age. A cytokine panel which best
represented the spectrum of immune process involved in
TB was analysed by multiplex bead-based enzyme-linked
immunosorbent assay. This included the Th1 (INF-𝛾, TNF-
𝛼) versus Th2 (IL-4, IL-5) balance, T-cell stimulation (IL-2,
IL-12), macrophage activation (IL-1𝛽), granuloma formation
(IL-8), limitation of inflammation (IL-10), and other inflam-
matory cytokines and chemokines (IL-6, GM-CSF, IL-15, and
IL-17).
2. Material and Methods
2.1. Patients. This study was conducted using a serum
bank from patients diagnosed with TB lymphadenitis. These
patients were recruited in an epidemiological study from
four districts: Babati, Karatu, Hanang, and Mbulu of the
Karatu region, Tanzania [10]. These patients were small-scale
farmers, cattle-keepers, and nomads. The characteristics of
the study population are provided in Table 1.
Diagnosis of TB lymphadenitis was based on strong
clinical evidence according to the National Tuberculosis and
Leprosy Control Programme clinical guidelines [11], that is,
history of TB exposure, history of chronic relapsing fever,
weight loss, and cervical swelling not responding to the
common antibiotics. This was followed by the decision by a
clinician to treat with a full course of anti-TB chemotherapy.
The majority of patients presented with swelling in the neck.
Other symptoms such as fever, pain, and weight loss were
infrequent. About 50% of patients gave a history of TB in
the family. History of previous TB treatment was given by
about 1% of patients. Cervical lymph nodes were the main
lymph nodes affected, enlarged in about 89% of the cases,
while the axillary, inguinal, andmesenteric lymphnodeswere
involved in a small proportion of cases [10]. In only 1% of
patients there was concomitant pulmonary TB, and in 99%
of patients no pulmonary or another extrapulmonary spread
than lymphadenitis was observed.
Sera from 23 healthy Tanzanian blood donors aged
between 18 and 70 were used as controls. These sera were
obtained from the blood bank at Muhimbili Medical Centre,
Dar es Salaam, Tanzania [12]. Skin tests or IGRA test for
mycobacterial infection was not performed in the study
subjects. BCG vaccination status was determined by history
of vaccination and the presence of vaccination scar.
2.2. Ethics Statement. Ethical clearance was obtained from
the National Medical Research Coordinating Committee in
Tanzania. The project was discussed with and was exempted
from ethical clearance inNorway as the principal investigator
and the patient material were from Tanzania. All the partic-
ipants provided their consent to participate in this study. In
case of minors, consent was obtained from the parents. The
consent was verbal as the study participants were from rural
Tanzania and could not read or write. This consent form was
approved by the ethics committee. The normal control sera
used in the study were obtained from the biobank left after
the completion of another study on the blood donors from
Tanzania [12]. These sera were stored at the University of
Bergen and permission to use these in this studywas obtained
from the responsible persons in Tanzania and Norway.
2.3. Collection and Storage of Blood Serum. Blood was drawn
from the patients using standardized phlebotomyprocedures.
Handling and processing were similar for all patients. Blood
samples were collected without anticoagulant into 10mL
BD vacutainer Z (Becton Dickinson & Company, NJ, USA)
and allowed to coagulate for 20 to 30 minutes at room
temperature. The sera were separated and transferred to
NUNC tubes (NUNC/Thermo Fischer, Roskilde, Denmark)
and stored at −20∘C. The NUNC tubes were labelled with
identification numbers to ensure the confidentiality of the
results. The samples were later shipped to the University of
Bergen, Norway, where they were aliquoted and stored at
−20∘C.
2.4. Culture and HIV Test Procedures. Open biopsy speci-
mens were taken from all patients before starting any anti-TB
chemotherapy. The specimens were divided into two, one for
culture and another for histology. The specimen for culture
was placed in a universal container and stored in a deep
freezer. These frozen biopsy specimens were processed for
culture using aseptic techniques in a safety cabinet. All speci-
menswere decontaminated, digested by standard procedures,
and inoculated onto Lowenstein-Jensen egg medium under
37∘C incubation for at least eight weeks.
For HIV testing, pre- and posttest counselling were
conducted, and patients were assured that the results would
be handled confidentially. HIV testing was performed using
single Behringer ELISA tests (Dade, Behring Marburg
GmbH, Emil-von-Behring Marburg, Germany). Positive
cases were repeated with Wellcozyme HIV Recombinant
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IFN-𝛾 0.0 (0–42.8) 0.0 (0–1.5) 0.001 0.0 (0–40.4) 0.268
TNF-𝛼 8.4 (0–352.5) 2.5 (0–51.7) 0.005 3.2 (0–33.4) 0.015
GM-CSF 35.2 (0–506.9) 0.0 (0–379.2) 0.007 0.0 (0–147.9) 0.023
IL-1𝛽 48.7 (0–6305.4) 0.0 (0–933.2) 0.004 4.0 (0–610.5) 0.338
IL-2 0.0 (0–28.2) 0.3 (0–16.3) 0.038 1.0 (0–105.6) 0.003
IL-4 0.0 (0–18.5) 0.0 (0–4.3) 0.002 0.0 (0–5.4) 0.208
IL-5 1.0 (0–10.0) 0.5 (0–12.5) 0.559 0.0 (0–1.5) 0.001
IL-6 47.4 (0–25781.5) 0.0 (0–9355.1) 0.000 44.1 (0–587.4) 0.244
IL-8 370.4 (0–386578.0) 65.9 (1.6–2888.2) 0.071 68.2 (0–3551.4) 0.195
IL-10 0.0 (0–29.3) 0.0 (0–36.2) 0.560 0.0 (0–9.9) 0.233
IL-12 0.0 (0–37.8) 2.7 (0–15.3) 0.000 0.0 (0–9.5) 0.701
IL-15 0.0 (0–61.4) 0.0 (0–12.7) 0.812 0.6 (0–53.3) 0.385
IL-17 0.0 (0–133.7) 0 0.282 0 0.262
∗
𝑃 value for difference between adult patients and healthy controls and ∗∗𝑃 value for difference between adult and pediatric patients.
(Murex Biotech, UK). Tests were conducted according to
the manufacturer’s protocol. Mycobacterial cultures were
conducted at the Central Tuberculosis Reference Laboratory
(CTRL) at NIMR Muhimbili Medical Centre, and HIV
testing at National Reference Laboratory, at Muhimbili Uni-
versity of Health and Allied Sciences, Tanzania.
2.5. Multiplex Cytokine Bead-Based Enzyme-Linked Im-
munosorbent Assay (ELISA). To detect cytokines in the
sera, a human cytokine thirteen-plex antibody bead assay
(Biosource, Camarillo, CA, USA) was used according to the
manufacturer’s instructions with a Luminex 100 System. IFN-
𝛾, TNF-𝛼, GM-CSF, IL-1𝛽, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10,
IL-12, IL-15, and IL-17 were quantified (pg/mL). A standard
curve was created from threefold dilution series of premixed
standards.The assay was performed in a 96-well filter bottom
plate supplied with the kit. Premixed beads coated with the
target antibodies were added to each well, followed by the
50𝜇L of incubation buffer. 100 𝜇L/well of the assay diluent
was subsequently added. Premixed standards and samples
were then added to the wells and incubated for 2 hours.
Subsequently premixed biotinylated detector antibody was
added to each well and incubated for 1 hour, followed by
incubation with Streptavidin-RPE for 30 minutes. All steps
were performed at room temperature, and the samples and
reagents were kept in the dark during the procedure. Between
each step the plates were washed twice and each incubation
step was performed on a rotating platform (600 rpm).
2.6. Data Management and Statistical Analysis. Statistical
analysis was conducted using SPSS for Windows. A non-
parametric Mann-Whitney test was used for two group
comparisons. Spearman’s rank correlation was performed to
determine the relationship between two variables. 𝑃 values
less than 0.05 were considered significant.
3. Results
3.1. Cytokines/Chemokines in Adult Patients. Table 2 shows
the cytokine levels in the adult TB lymphadenitis patients
and healthy blood donors from Tanzania. Serum levels of
IFN-𝛾, TNF-𝛼, GM-CSF, IL-1𝛽, IL-2, IL-4, and IL-6 were
higher in the patients compared with healthy controls, while
IL-12 levels were lower. Serum levels of IL-5, IL-8, IL-
10, IL-15, and IL-17 were not statistically different in the
two groups. There was a large variation in the amount of
different cytokines in the sera of both patients and controls.
Table 3 shows the correlations between various cytokines and
chemokines. There was a positive correlation among IFN-
𝛾, TNF-𝛼, GM-CSF, IL-1𝛽, IL-6, and IL-8. Th1 cytokines
IFN-𝛾 and TNF-𝛼 also correlated positively with the anti-
inflammatory cytokine IL-10.
3.2. Differences in the Cytokine/Chemokines between Adults
and Children. The levels of cytokines were generally lower in
children as compared to adults with exception of IL-2 which
was higher (Table 2). However, the statistically significant
differences were only observed between serum levels of TNF-
𝛼, GM-CSF, and IL-5 and IL-2. There was a significant
positive correlation among IFN-𝛾, TNF-𝛼, GM-CSF, IL-6,
and IL-8. Unlike the adult population, a negative correlation
was observed between IL-5 and IL-12 and no significant
positive correlation was observed between IFN-𝛾 and TNF-𝛼
with anti-inflammatory IL-10 (Table 4).
3.3. Difference in Cytokines/Chemokines between Male and
Female Adult Patients. The female adults had significantly
lower levels of IL-17 and higher levels of IL-12 compared with
the male adult patients (Table 5).
3.4. Relation of Cytokine/Chemokine Levels with Mycobacte-
rial Culture. As detection of mycobacteria by culture reflects
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Table 3: Relationship between the serum levels of cytokines in adult patients with tuberculous lymphadenitis (𝑛 = 61) based on Spearman’s
rank correlation. The values shown are the correlation coefficients.
TNF-𝛼 GM-CSF IL-1𝛽 IL-2 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-15 IL-17
IFN-𝛾 .729∗∗ .741∗∗ .723∗∗ .058 .018 .252∗ .732∗∗ .551∗∗ .335∗∗ −.193 −.025 .178
TNF-𝛼 .828∗∗ .724∗∗ .081 .055 .217 .674∗∗ .577∗∗ .315∗ −.035 .119 −.103
GM-CSF .723∗∗ .062 −.012 .230 .794∗∗ .651∗∗ .210 −.063 .075 −.051
IL-1𝛽 .213 .312∗ .287∗ .687∗∗ .539∗∗ .275∗ −.109 .208 .154
IL-2 .150 .275∗ .076 −.028 .181 .183 .454∗∗ .086
IL-4 .061 −.012 .068 .034 −.207 .037 .251
IL-5 .138 .261∗ .241 .022 .188 −.134
IL-6 .597∗∗ .066 −.038 −.050 .050
IL-8 .123 −.011 −.057 .076
IL-10 −.043 .068 .218
IL-12 .459∗∗ −.171
IL-15 .011
∗∗Correlation is significant at the 0.01 level (2-tailed). ∗Correlation is significant at the 0.05 level (2-tailed).
Table 4: Relationship between the serum levels of cytokines in children with tuberculous lymphadenitis (𝑛 = 25) based on Spearman’s rank
correlation. The values shown are the correlation coefficients.
TNF-𝛼 GM-CSF IL-1𝛽 IL-2 IL-4 IL-5 IL-6 IL-8 IL-10 IL-12 IL-15
IFN-𝛾 .566∗∗ .716∗∗ .369 −.244 .389 .274 .440∗ .497∗ .151 −.200 −.111
TNF-𝛼 .802∗∗ .611∗∗ .028 .213 .303 .528∗∗ .648∗∗ .108 −.047 .291
GM-CSF .726∗∗ .039 .442∗ .527∗∗ .758∗∗ .875∗∗ .026 −.191 .154
IL-1 .336 .490∗ .646∗∗ .596∗∗ .671∗∗ −.176 −.114 .424∗
IL-2 −.226 −.039 .122 .150 −.133 .256 .448∗
IL-4 .745∗∗ .341 .376 .008 −.391 −.076
IL-5 .401∗ .469∗ .070 −.538∗∗ −.038
IL-6 .842∗∗ −.190 −.282 .072
IL-8 −.068 −.115 .194
IL-10 −.259 −.474∗
IL-12 .530∗∗
∗∗Correlation is significant at the 0.01 level (2-tailed). ∗Correlation is significant at the 0.05 level (2-tailed).
Table 5: Differences in the serum cytokine levels in the adult Tanzanian patients based on gender and mycobacterial culture from lymph
nodes.
Cytokine (pg/mL) Male (𝑛 = 27)Median (range)
Female (𝑛 = 34)









IFN-𝛾 0.0 (0–42.8) 0.0 (0–30.9) 0.98 0.0 (0–22.4) 0.0 (0–42.8) 0.383
TNF-𝛼 3.2 (0–352.5) 11.8 (0–73) 0.15 8.4 (0.5–352.5) 12.4 (0–72.9) 0.874
GM-CSF 35.2 (0–507) 55.1 (0–457) 0.96 35.2 (0–506.9) 34.5 (0–457.7) 0.864
IL-1𝛽 72.6 (0–1338) 5.7 (0–6305) 0.51 0.0 (0–1338.8) 66.5 (0–6305.4) 0.746
IL-2 0.0 (0–28) 0.0 (0–19.8) 0.31 0.0 (0–28.2) 0.0 (0–19.8) 0.193
IL-4 0 (0–9.5) 0 (0–18) 0.30 0.0 (0–6.8) 0.0 (0–18.5) 0.360
IL-5 1.5 (0–10) 0.75 (0–6.4) 0.16 1.0 (0–8.1) 1.0 (0–10.0) 0.465
IL-6 46.4 (0–18979) 55.5 (0–25781) 0.80 46.4 (0–18979.1) 55.6 (0–25781.5) 0.825
IL-8 362 (0–27670) 419 (0–386577) 0.70 638.2 (0–27670.3) 366.4 (0–386578.0) 0.486
IL-10 0.0 (0–29) 0.0 (0–22) 0.96 0.0 (0–29.3) 0.0 (0–22.8) 0.513
IL-12 0 (0–20.7) 0.1 (0–37) 0.03 0.3 (0–20.7) 0.0 (0–37.8) 0.029
IL-15 0.0 (0–61) 0.0 (0–25) 0.77 0.6 (0–21.1) 0.0 (0–61.4) 0.223
IL-17 0 (0–134) 0 0.04 0.0 (0–26.1) 0.0 (0–133.7) 0.638
∗
𝑃 value for difference between males and females and ∗∗𝑃 value for difference between culture positive and culture negative TB patients.
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the lesionswith higher bacillary load, a comparisonwasmade
between he culture-positive and culture-negative cases to
see how this difference is reflected in the immune response.
Among the adult patients, 13 (21%) cases were culture-
positive and these cases had higher level of IL-12 compared
with culture-negative cases (Table 5). IL-12 correlated posi-
tively only with IL-15 in culture-positive patients. The levels
of the other cytokines were not statistically different. Among
children culture results were available for 23 cases and 3
(13%) caseswere culture-positive.The levels of cytokineswere
not statistically different between the two groups. When the
adult and paediatric patients were combined, the difference
in culture-positive and culture-negative cases was similar to
that in the adult patients.
4. Discussion
Pathogenicmycobacteria are known to stimulate the immune
response in such a way that the eradication of the pathogen is
not fully achieved and the inappropriately simulated immune
response leads to tissue destruction and the progression of
disease rather than achieving the eradication of infection
[5, 13–15]. In this study there were higher levels of the
proinflammatory cytokines IFN-𝛾, IL-2, and TNF-𝛼, and the
chemokines GM-CSF, IL-1𝛽, and IL-6 among TB cases as
compared to controls. The levels of the anti-inflammatory
cytokines IL-10 and IL-5 which are expected to balance the
proinflammatory cytokines were not different between TB
cases and controls.These findings imply that a relative lack of
anti-inflammatory cytokines and thereby reduced inhibition
of immune response toM. tuberculosismay be responsible for
disease progression.
Lower levels of TNF-𝛼 andGM-CSF in sera from children
comparedwith adultsmay indicate that the immune response
in children may not be as effective as that in adults to
control TB as both GM-CSF and TNF-𝛼 have been associated
with increased resistance to mycobacterial infection [16,
17]. This may explain an increased preponderance of TB
lymphadenitis among children. A recent study has indeed
shown that healthy children generally secrete lower levels of
cytokines as compared to adults [18]. One weakness of the
study is that we do not have control sera from age-matched
healthy children. Therefore, the serum levels of pediatric
patients were not compared with the controls.
A higher female preponderance for TB lymphadenitis in
adults has been suggested to be due to differences in the
immune response [2, 19]. In this study the female patients had
lower levels of IL-17 and higher levels of IL-12 compared with
adult male patients. Production of IL-17 is shown to be neg-
atively regulated by IL-12 in human T cells [20]. Recent find-
ings suggest a role for IL-17-producing Th17 cells in TB with
an early but transientTh17 burstwhich apparently contributes
to protectionwhereas long lastingTh17 activity causes pathol-
ogy [21–23].The balance between IL17 and IL12 may partially
explain the increased susceptibility of females as compared
to males. However due to large dispersion in the data and
several observations below the detection limit of the assay, it
is difficult to make any firm conclusion. Further studies are
required to understand the significance of these differences.
In this study, IL-12 p40 concentrations were lower in
patients with active TB than in healthy controls. Para-
doxically, patients with positive cultures had significantly
higher IL-12 serum levels than culture-negative TB patients.
Considering the essential role of IL-12 in a protective immune
response to TB and that positive cultures are associated
with a higher mycobacterial burden, it is difficult to explain
this finding. IL-12 correlated positively only with IL-15
in all patients and in culture-positive patients. These two
cytokines have been shown to activate natural killer cell
function [24]. However no difference in the levels of other
cytokines/chemokines between culture positive and negative
patients suggests that TB lymphadenitis severity may result
mainly from the immune response rather than the bacterial
load in the tissues.
5. Conclusion
As compared with the controls, TB lymphadenitis patients
secreted more proinflammatory cytokines and chemokines,
except IL-12, while the levels of the anti-inflammatory
cytokines were not different suggesting the role of inap-
propriate immune stimulation in the disease pathogenesis.
There were significant differences in the levels of circulating
cytokines with respect to gender and age. Children had
generally lower levels of cytokines as compared to adults, and
significantly lower levels of TNF-𝛼 andGM-CSF indicate that
the immune response in children may not be as effective as
that in adults which couldmake themmore susceptible to TB.
Female patients had lower levels of IL-17 and higher levels of
IL-12 comparedwithmale patients; however these findings do
not support that female preponderance is due to differences
in immune response.
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